CN101693009A - 牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法 - Google Patents

牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法 Download PDF

Info

Publication number
CN101693009A
CN101693009A CN200910308871A CN200910308871A CN101693009A CN 101693009 A CN101693009 A CN 101693009A CN 200910308871 A CN200910308871 A CN 200910308871A CN 200910308871 A CN200910308871 A CN 200910308871A CN 101693009 A CN101693009 A CN 101693009A
Authority
CN
China
Prior art keywords
solution
closantel sodium
parts
sheep
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN200910308871A
Other languages
English (en)
Other versions
CN101693009B (zh
Inventor
要瑞丽
聂江力
裴毅
元军英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Bijia Pharmaceutical Co., Ltd.
Original Assignee
TIANJIN BIJIA PHARMACEUTICAL GROUP CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIANJIN BIJIA PHARMACEUTICAL GROUP CO Ltd filed Critical TIANJIN BIJIA PHARMACEUTICAL GROUP CO Ltd
Priority to CN 200910308871 priority Critical patent/CN101693009B/zh
Publication of CN101693009A publication Critical patent/CN101693009A/zh
Application granted granted Critical
Publication of CN101693009B publication Critical patent/CN101693009B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及一种牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法,构成组分及其体积份数分别为:乙酸乙酯5-15份;二甲基亚砜20-30份;氮酮2-6份;异丙醇1-3份;丙二醇或乙醇50-70份;氯氰碘柳胺钠含量为每100ml溶液含2.5-5g,经过溶解、混合、过滤、灌装后制成成品。本发明涉及的氮酮是新型的皮肤渗透促进剂,能增加皮肤对许多不同类型药物的经皮吸收,有效避免肝过效应,避免药物吸收过程的峰谷现象,降低了药物与剂量相关引起的毒副作用,延长有效作用时间,改变给药面积有效调节给药剂量,减少个体间差异,具有使用简单、方便、快捷的特点,较其它剂型更适于牧区抗寄生虫的防治和驱杀。

Description

牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法
技术领域
本发明属于药物制备技术领域,尤其是一种牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法。
背景技术
透皮制剂系经皮给药的新剂型,即药物透过皮肤的毛细血管进入全身经血液循环达到有效血药浓度,药物在各组织或病变部位发挥治疗或预防疾病的作用。与普通制剂相比,透皮制剂具有避免如肝过效应及胃肠灭活等由口服给药及胃肠给药等引发的副作用、维持恒定的血药浓度、延长有效作用时间等三个方面的优点。
氯氰碘柳胺钠对牛、羊片形吸虫、捻转血矛线虫以及某些节肢动物均有驱除活性,对多数胃肠道线虫,如血矛线虫、仰口线虫、食道口线虫,除虫率均超过90%,可有效驱除犬钩虫,此外对1、2、3期羊鼻绳蛆均有100%杀灭效果。
寄生虫对牛羊的危害主要是通过消耗牛羊体内的营养物质,造成机械损伤,或缺乏营养,使牛羊对饲料的利用率下降,导致牛羊生长缓慢,饲料利用率降低。目前,抗寄生虫类药物使用最广泛的剂型是注射剂、片剂和浇泼剂,其中浇泼剂以体外驱虫为主,真正运用透皮吸收的作用机理进行体内外驱虫的药物极少。
发明内容
本发明的目的是克服现有技术的不足,提出一种给药途径新、副作用小、药效作用持续时间长、个体差异小以及使用方便的牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法。
本发明实现目的的技术方案是:
一种牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液,构成组分及其体积份数分别为:
乙酸乙酯      5-15份;二甲基亚砜    20-30份;
氮酮          2-6份; 异丙醇        1-3份;
丙二醇或乙醇  50-70份;
氯氰碘柳胺钠加入质量为上述药液总体积的2.5-5%。
一种牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液的制备方法,步骤是:
(1)将处方量的氯氰碘柳胺钠在搅拌下放入乙酸乙酯中至完全溶解,得到氯氰碘柳胺钠溶液;
(2)在氯氰碘柳胺钠溶液中边搅拌边加入处方量的二甲基亚砜、异丙醇、氮酮,混合均匀;
(3)混合后用丙二醇或乙醇稀释定溶;
(4)将得到的混合液用微孔滤膜过滤;
(5)在滤液澄清度合格后灌装,即得氯氰碘柳胺钠透皮溶液。
而且,所述微孔滤膜孔径为1.2μm。
本发明的优点和有益效果为:
1、本发明创新了抗寄生虫药物给药途径,其配方中氮酮和二甲基亚砜用药12小时后透过量达到90.1%,超过标准透过量,充分体现了经皮吸收在抗寄生虫病的制剂优势,是国内抗寄生虫病制剂加工技术的重大突破,为国内抗寄生虫病治疗开辟了新途径。
2、本发明配方中涉及的氮酮是新型的皮肤渗透促进剂,它能增加皮肤对许多不同类型药物的经皮吸收,制备的含有氮酮的药液经附属器空隙进入真皮毛细血管被吸收,能有效避免肝过效应,降低药物分解率,避免药物吸收过程的峰谷现象,降低了药物或剂量等因素引起的毒副作用,延长有效作用时间,改变给药面积,并有效调节给药剂量、减少个体间差异,具有使用简单、方便、快捷的特点,较其它剂型更适于牧区抗寄生虫的防治。
3、本发明涉及的工艺具有生产设备简单、操作容易,使用方便、适合扩大生产的优点,弥补了国内兽药市场在某些剂型的空白,创新了给药途径,广泛用于防治牛、羊肝片吸虫、胃肠道线虫病及羊狂绳蛆病等寄生虫病的防治。
具体实施方式
下面通过具体实施例对本发明作进一步详述,以下实施例只是描述性的,不是限定性的,不能以此限定本发明的保护范围。
下面实施例中,每100ml药液中需要加入氯氰碘柳胺钠为2.5-5g。
实施例1:
一种牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液,其构成组分及其重量份数分别为(按每100ml原辅料配比,以下实施例同):
氯氰碘柳胺钠    2.5g
乙酸乙酯        10ml
二甲基亚砜    24ml
氮酮          4ml
异丙醇        2ml
丙二醇        58ml。
本发明所涉及的氯氰碘柳胺钠透皮溶液的原料药为氯氰碘柳胺钠,其别名是:N -{5-氯-4[(4-氯苯基)氰甲基]-2-甲苯基}-2-羟基-3,5-二碘苯甲酰钠盐。
一种牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液制备方法,包括如下步骤:
(1)将处方量的氯氰碘柳胺钠在搅拌下放入乙酸乙酯中至完全溶解,得到氯氰碘柳胺钠溶液;
(2)在氯氰碘柳胺钠溶液中边搅拌边加入处方量的二甲基亚砜、异丙醇、氮酮,混合均匀;
(3)混合后用丙二醇稀释定溶;
(4)将得到的混合液用微孔滤膜过滤;
(5)滤液澄清度合格后灌装,即得氯氰碘柳胺钠透皮溶液。
实施例2:
一种畜用抗寄生虫病氯氰碘柳胺钠透皮溶液,其构成组分及其重量份数分别为:
氯氰碘柳胺钠   5g
乙酸乙酯       10ml
二甲基亚砜     25ml
氮酮           4ml
异丙醇         2ml
丙二醇         60ml。
本实施例制备方法的步骤同于实施例1。
实施例3:
一种畜用抗寄生虫病氯氰碘柳胺钠透皮溶液,其构成组分及其重量份数分别为:
氯氰碘柳胺钠      5g
乙酸乙酯          10ml
二甲基亚砜        25ml
氮酮        4ml
异丙醇      2ml
乙醇        58ml。
本实施例的制备方法的步骤同于实施例1。
检测数据:该药物配方中的氮酮和二甲基亚砜用药12小时后,其透过量达到90.1%,超过标准透过量。

Claims (3)

1.一种牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液,其特征在于:构成组分及其体积份数分别为:
乙酸乙酯     5-15份;二甲基亚砜    20-30份;
氮酮         2-6份;异丙醇         1-3份;
丙二醇或乙醇 50-70份;
氯氰碘柳胺钠加入质量为上述药液总体积的2.5-5%。
2.一种如权利要求1所述的牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液的制备方法,其特征在于:制备的步骤是:
(1)将处方量的氯氰碘柳胺钠在搅拌下放入乙酸乙酯中至完全溶解,得到氯氰碘柳胺钠溶液;
(2)在氯氰碘柳胺钠溶液中边搅拌边加入处方量的二甲基亚砜、异丙醇、氮酮,混合均匀;
(3)混合后用丙二醇或乙醇稀释定溶;
(4)将得到的混合液用微孔滤膜过滤;
(5)在滤液澄清度合格后灌装,即得氯氰碘柳胺钠透皮溶液。
3.根据权利要求2所述的牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液的制备方法,其特征在于:所述微孔滤膜孔径为1.2μm。
CN 200910308871 2009-10-27 2009-10-27 牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法 Expired - Fee Related CN101693009B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200910308871 CN101693009B (zh) 2009-10-27 2009-10-27 牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200910308871 CN101693009B (zh) 2009-10-27 2009-10-27 牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法

Publications (2)

Publication Number Publication Date
CN101693009A true CN101693009A (zh) 2010-04-14
CN101693009B CN101693009B (zh) 2010-12-01

Family

ID=42092037

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200910308871 Expired - Fee Related CN101693009B (zh) 2009-10-27 2009-10-27 牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法

Country Status (1)

Country Link
CN (1) CN101693009B (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106176586A (zh) * 2016-07-22 2016-12-07 柳州市柳南区安顺养殖协会 一种牛羊用抗寄生虫病碘醚柳胺透皮溶液
CN109674739A (zh) * 2019-01-25 2019-04-26 西藏农牧学院 一种防治牦牛寄生虫病的透皮搽剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1137379A (zh) * 1996-06-24 1996-12-11 陈西钊 爱比菌素浇泼剂
CN1258505A (zh) * 1999-08-06 2000-07-05 王玉万 一种含阿维菌素、伊维菌素或氯氰碘柳胺钠的动物用抗寄生虫乳剂
CN1362062A (zh) * 2001-01-02 2002-08-07 王玉万 含丙硫苯咪唑和氯氰碘柳胺的复方兽用抗寄生虫制剂
CN1608618A (zh) * 2003-06-23 2005-04-27 王玉万 含氯氰碘柳胺或其钠盐的兽用注射剂
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
CN101422476A (zh) * 2007-10-31 2009-05-06 天津生机集团有限公司 兽用复方氯氰碘柳胺钠注射液

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106176586A (zh) * 2016-07-22 2016-12-07 柳州市柳南区安顺养殖协会 一种牛羊用抗寄生虫病碘醚柳胺透皮溶液
CN109674739A (zh) * 2019-01-25 2019-04-26 西藏农牧学院 一种防治牦牛寄生虫病的透皮搽剂及其制备方法

Also Published As

Publication number Publication date
CN101693009B (zh) 2010-12-01

Similar Documents

Publication Publication Date Title
CN101579309B (zh) 家畜用抗寄生虫病伊维菌素透皮溶液及其制备方法
CN1283990A (zh) 含有氢化蓖麻油的长效注射制剂
CN105853454A (zh) 一种广谱抗寄生虫药纳米乳剂及其制备方法
CN111803516A (zh) 一种维生素c氯化钠注射液及其制备方法和应用
CN101693009B (zh) 牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法
CN105343032B (zh) 一种芬苯达唑微囊及其制备方法
CN100522243C (zh) 动物皮肤渗透剂
CN111514157A (zh) 组合物在制备兽用抗寄生虫病药物中的应用、兽用抗寄生虫病的透皮溶液及其制备方法
RU2464979C1 (ru) Препарат для лечения и профилактики послеродового эндометрита и синдрома метрит-мастит-агалактии у свиноматок
US6174866B1 (en) Edible anti-parasite medication for domesticated animals
CN103830165A (zh) 一种牛羊用抗寄生虫病碘醚柳胺透皮溶液及其制备方法
KR101687973B1 (ko) 마이크로필름 코팅을 이용한 동물 사료용 프리믹스 제조방법
JP5399395B2 (ja) カワラヨモギを含有する家畜の産乳量増加用組成物
CN102895180A (zh) 牛羊用抗寄生虫病复方三氯苯达唑透皮溶液及其制备方法
CN1533770A (zh) 含苯并咪唑类驱虫药物的混悬注射剂
RU2622017C1 (ru) Способ лечения мастита у лактирующих коров
CN112972437B (zh) 一种包含碘硝酚的长效外用制剂及其制备方法和用途
RU2320352C2 (ru) Способ лечения субклинического мастита у коров
CN109394697A (zh) 一种防治鸡兔球虫病的地克珠利缓释制剂及其制备方法
US12017998B1 (en) 5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid as an antimicrobial compound
RU2052266C1 (ru) Способ лечения гепатоза коров
CN103417477A (zh) 一种以水为基质的多拉菌素o/w型注射液及其制备方法
US11932593B1 (en) 8-(3-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound
CN103396452B (zh) 一种核黄素磷酸钠化合物及其组合物
US11970439B1 (en) 8-(4-chlorobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: NIUSULE (TIANJIN) BEHIGH BIOPHARMACEUTICAL CO., LT

Free format text: FORMER OWNER: TIANJIN BIJIA PHARMACEUTICAL GROUP CO., LTD.

Effective date: 20100925

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20100925

Address after: 300380 Tianjin City, Xiqing Economic Development Zone Industrial Park Xin Taihua Road No. 38

Applicant after: Niusule Bijia (Tianjin) Pharmaceutical Group Co., Ltd.

Address before: 300380 Tianjin City, Xiqing Economic Development Zone Industrial Park Xin Taihua Road No. 38

Applicant before: Tianjin Bijia Pharmaceutical Group Co.,Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Antiparasitic closantel sodium transdermal solution for ox and sheep and preparation method thereof

Effective date of registration: 20120625

Granted publication date: 20101201

Pledgee: Bank of Dalian Co Tianjin branch

Pledgor: Niusule Bijia (Tianjin) Pharmaceutical Group Co., Ltd.

Registration number: 2012990000321

C56 Change in the name or address of the patentee

Owner name: TIANJIN BIJIA PHARMACEUTICAL GROUP CO., LTD.

Free format text: FORMER NAME: NIUSULE BEHIGH (TIANJIN) PHARMACEUTICALS GROUP CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: 300380 Tianjin City, Xiqing Economic Development Zone Industrial Park Xin Taihua Road No. 38

Patentee after: Tianjin Bijia Pharmaceutical Group Co.,Ltd.

Address before: 300380 Tianjin City, Xiqing Economic Development Zone Industrial Park Xin Taihua Road No. 38

Patentee before: Niusule Bijia (Tianjin) Pharmaceutical Group Co., Ltd.

PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20130626

Granted publication date: 20101201

Pledgee: Bank of Dalian Co Tianjin branch

Pledgor: Tianjin Bijia Pharmaceutical Group Co.,Ltd.

Registration number: 2012990000321

PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Antiparasitic closantel sodium transdermal solution for ox and sheep and preparation method thereof

Effective date of registration: 20130626

Granted publication date: 20101201

Pledgee: Bank of Dalian Co Tianjin branch

Pledgor: Tianjin Bijia Pharmaceutical Group Co.,Ltd.

Registration number: 2013990000408

PLDC Enforcement, change and cancellation of contracts on pledge of patent right or utility model
PM01 Change of the registration of the contract for pledge of patent right

Change date: 20130626

Registration number: 2012990000321

Pledgor after: Tianjin Bijia Pharmaceutical Group Co.,Ltd.

Pledgor before: Niusule Bijia (Tianjin) Pharmaceutical Group Co., Ltd.

C56 Change in the name or address of the patentee

Owner name: TIANJIN BIJIA PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: TIANJIN BIJIA PHARMACEUTICAL GROUP CO., LTD.

CP03 Change of name, title or address

Address after: 300380 Tianjin city Xiqing district and Industrial Park Taihua Road No. 38

Patentee after: Tianjin Bijia Pharmaceutical Co., Ltd.

Address before: 300380 Tianjin City, Xiqing Economic Development Zone Industrial Park Xin Taihua Road No. 38

Patentee before: Tianjin Bijia Pharmaceutical Group Co.,Ltd.

PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Antiparasitic closantel sodium transdermal solution for ox and sheep and preparation method thereof

Effective date of registration: 20150210

Granted publication date: 20101201

Pledgee: Tianjin Binhai commercial bank, Limited by Share Ltd, Nanjing Branch

Pledgor: Tianjin Bijia Pharmaceutical Co., Ltd.

Registration number: 2015120000015

PM01 Change of the registration of the contract for pledge of patent right

Change date: 20150203

Registration number: 2013990000408

Pledgor after: Tianjin Bijia Pharmaceutical Co., Ltd.

Pledgor before: Tianjin Bijia Pharmaceutical Group Co.,Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101201

Termination date: 20151027

EXPY Termination of patent right or utility model